VectorBuilder Inc. – a global leader in gene delivery technologies – recently announced the completion of $57 million funding, which was co-led by Legend Capital. The fund will support the construction of VectorBuilder’s new Gene Delivery Research and Manufacturing Campus, and further boost the company’s R&D capabilities and global business pre.
Is now the time to invest in Kazakhstan? - A major new report from The Chamber of International Commerce of Kazakhstan finds strong and growing interest from international investors and companies. A full copy of the report can be downloaded here. International investors Franklin Templeton, VPE Capital and Vedra .
The Companies sign a strategic long-term global partnership in RRP Japan Tobacco (JT) (TSE: 2914) announced today that the JT Group, through its subsidiary JTI, has entered into a joint venture (JV) with Altria Group (Altria), through its subsidiary PM USA, to market and commercialize heated tobacco sticks (HTS).
Combining KYOCERA AVX's leadership in discrete and module packaging along with VisIC's expertise in GaN power devices to offer cutting-edge products, including the highest efficiency power module for lead EV OEM and Tier 1 traction inverters. VisIC Technologies, a global leader in Gallium Nitride (GaN) solutions.
Landmark donation from alumnus Dr. Victor Phillip Dahdaleh will accelerate advances in global health using genomic medicine to inform patient diagnosis and care A landmark donation to support McGill University's renowned genomics research and education programs from UK-based alumnus and long-time donor Dr. Victo.